Statement of deviation(s) or variation(s) under Reg. 32

Date: 04th November 2026 BSE Limited, National Stock Exchange of India Limited, 20th Floor, P.J. Towers, Dalal Street, Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Mumbai – 400001, Maharashtra, India Bandra (E), Mumbai – 400 051, Maharashtra, India BSE Scrip Code: 544888 NSE Scrip Symbol: AUGMONT Subject: Submission of Statement prescribed under Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, for the quarter ended 30th September 2026: Dear Sir(s) / Madam(s), Pursuant to Regulation 32(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended from time to time, we hereby declare that the proceeds of the public issue of the Company, raised during the quarter ended 30th September 2026, were used for the purpose stated in the offer document and further, there has been no material deviation in use of proceeds of such issue, from the objects stated in the offer document of the issue. A statement to that effect, for the quarter ended 30th September 2026, as prescribed under the aforesaid regulation, is enclosed herewith as “Annexure A” and the same has been duly reviewed and approved by the Audit Committee and Board of Directors of the Company at their respective meetings held on 04th November 2026. This intimation / disclosure is being submitted for your information and records. You are requested to kindly take the same on record and disseminate it appropriately to all concerned. For Augmont Enterprises Limited (formerly known as Augmont Enterprises Private Limited) Sunny Parekh Company Secretary and Compliance Officer Membership No.: ACS32611 Annexure A Statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. Name of listed entity Augmont Enterprises Limited (formerly known as Augmont Enterprises Private Limited) Mode of Fund Raising Public Issues Date of Raising Funds 27/08/2026 Amount Raised (in Rs. Crores) 620.00 Report filed for Quarter ended 30th September 2026 Monitoring Agency Applicable Monitoring Agency Name, if applicable CARE Ratings Limited Is there a Deviation / Variation in use of funds No raised If yes, whether the same is pursuant to change in - terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval - Explanation for the Deviation / Variation - Comments of the Audit Committee after review - Comments of the auditors, if any - Objects for which funds have been raised and Not Applicable where there has been a deviation, in the following table Original Object Modified Original Modified Funds Amount of Remarks, if any Object, if Allocation allocation, Utilized Deviation/ any (Rs. In if any (Rs. In Variation Crore) Crore) for the quarter according to applicable object (Rs. In Crore) Funding future working N.A. 465 N.A. 465.23 0.00 N.A. capital requirements towards procurement, maintenance and scaling up of inventory and funding advance margin requirements for procurement of inventory by our Company. General Corporate Purpose. N.A. 107.76 N.A. 107.76 0.00 N.A. Offer Expense. N.A. 47.24 N.A. 0.41 46.60 N.A. Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund-raising document i.e. prospectus, letter of offer, etc.